Nektar Therapeutics today announced the appointment of Pushpinder Bindra as Managing Director of Nektar Therapeutics (India) Private Limited, a wholly owned subsidiary of Nektar Therapeutics. Mr. Bindra will report directly to Nektar’s Chief Operating Officer, Bharatt Chowrira, Ph.D., J.D.
In this newly created position, Mr. Bindra will oversee all of Nektar’s operations in India, including research, chemistry, manufacturing and control activities, as well as manage the new, 16-acre, 60,000 square foot, state-of-the-art research and development facility under construction behind the ICICI Knowledge Park, which is expected to be completed in August of this year.
“We are delighted to welcome Mr. Bindra, a leader of such high caliber, to the Nektar India team. During his approximately 30-year career, among other achievements, Pushpinder played a pivotal role in the successful transformation of Ranbaxy Laboratories from a small, regional company to India’s premier pharmaceutical firm. His proven leadership abilities, coupled with extensive expertise in global manufacturing will be invaluable to Nektar as we continue to expand within this key market,” stated Dr. Chowrira.
Prior to joining Nektar, Mr. Bindra, was Chief Operations Offer and a member of the Board of Directors of Glenmark Generics Limited, India, where he provided leadership across multiple areas of the company including research and development, manufacturing, quality assurance and finance, and helped to develop and execute strategies to increase market share and ensure the continued financial and operational growth of the company.
Previously, Mr. Bindra held various positions of increasing responsibility at Ranbaxy Laboratories Limited, India’s largest pharmaceutical company; most recently as President and Chief Technical Officer. In that capacity, Mr. Bindra successfully integrated various acquisitions throughout the organization, created world-class cGMP (current good manufacturing practices) manufacturing processes, ensured continuous regulatory compliance among all plants and oversaw annual capital expenditures of over $100 million, worldwide. During his 27 year tenure with the company, Mr. Bindra also held the positions of President Global Manufacturing, Senior Vice President Global Manufacturing and Supply Chain, and Vice President Pharma Manufacturing, among others.
Mr. Bindra received a Bachelor’s degree in Mechanical Engineering from Punjab University, India and an MBA degree from the University of Detroit. He holds a National Award for Outstanding Achievement and Contribution to the Indian Pharmaceutical Industry from the Indian Pharmaceutical Association, and a National Award for Leadership in Chemical Industry from the Chemical Engineering Institute of India.
Mr. Bindra noted, “I am honored to join Nektar, the industry leader in polymer conjugate chemistry, and am excited about the opportunity to recruit and mentor top-notch R&D talent to Nektar as we build world-class operations in India to execute on Nektar’s strategy to continue to develop high-value therapeutics with its proven technology platform.”